Bristol-Myers Squibb
BMY
#169
Rank
NZ$201.52 B
Marketcap
NZ$98.96
Share price
-2.12%
Change (1 day)
-1.79%
Change (1 year)

EPS for Bristol-Myers Squibb (BMY)

EPS in 2025 (TTM): NZ$5.12

According to Bristol-Myers Squibb's latest financial reports the company's current EPS (TTM) is NZ$5.06. In 2024 the company made an earnings per share (EPS) of NZ-$7.53 a decrease over its 2023 EPS that were of NZ$6.61.

EPS history for Bristol-Myers Squibb from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$5.12-168.01%
2024NZ-$7.53-213.92%
2023NZ$6.6130.2%
2022NZ$5.07-6.04%
2021NZ$5.40-179.29%
2020NZ-$6.81-281.37%
2019NZ$3.76-27.21%
2018NZ$5.16
2016NZ$4.55175.26%
2015NZ$1.65-19.83%
2014NZ$2.06-22.44%
2013NZ$2.6634.48%
2012NZ$1.98

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$18.97 275.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$12.53 147.81%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$2.32-54.21%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$4.07-19.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$39.20 675.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$24.40 382.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$3.52-30.47%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
NZ$18.71 270.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$12.44 146.02%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$9.11 80.13%๐Ÿ‡ฌ๐Ÿ‡ง UK